• Leupeptin Hemisulfate Salt: Precision Control in Protein Deg

  2026-07-15

  Leupeptin hemisulfate salt stands out as a nanomolar-potency tool for regulating protease activity in protein degradation, viral replication, and metabolic-epigenetic research. This article unpacks optimized experimental workflows, real-world troubleshooting, and protocol innovations that help researchers unlock reproducibility and insight using APExBIO's Leupeptin, Microbial.

• Pregnenolone Carbonitrile: Precision PXR Modulation for Live

  2026-07-14

  This thought-leadership article unpacks the mechanistic and translational impact of Pregnenolone Carbonitrile (PCN) as a benchmark rodent PXR agonist. It directly connects gene regulatory mechanisms with disease modeling, incorporates new evidence from MASLD/MASH pharmacokinetics, and provides actionable protocol guidance for translational researchers. The discussion is advanced by integrating recent findings on transporter and CYP3A induction, positioning APExBIO's PCN as an essential tool for next-generation hepatic disease research.

• Oseltamivir Acid: Pharmacokinetic Precision and Translationa

  2026-07-14

  Explore how Oseltamivir acid, a leading influenza neuraminidase inhibitor, enables precise influenza antiviral research through advanced pharmacokinetics and actionable assay insight. Discover new perspectives on resistance, solubility, and translational models that set this article apart.

• miR-196a Drives Esophageal Adenocarcinoma via MYC/TERT/NFκB

  2026-07-13

  The referenced study demonstrates that microRNA-196a promotes the aggressiveness of esophageal adenocarcinoma through coordinated activation of the MYC/TERT/NFκB axis, directly linking microRNA regulation to epithelial-to-mesenchymal transition (EMT) and tumor progression. These findings highlight the potential of targeting c-Myc as part of translational cancer research strategies.

• Phenacetin (N-(4-ethoxyphenyl)acetamide): Structural Insight

  2026-07-13

  Explore the scientific basis for using Phenacetin in research, including its structure, solubility, and safety profile. This article uniquely examines how advanced mechanistic and metabolic knowledge can optimize assay design and compound selection in drug discovery.

• Standardized Whole-Blood Stimulation Reveals Metabolic Contr

  2026-07-12

  This study presents a robust protocol integrating metabolic modulation into standardized whole-blood stimulation assays to dissect immune response variability. By employing metabolic inhibitors, the authors demonstrate how targeted pathway interventions selectively alter cytokine profiles, providing new avenues for immunometabolism research.

• Iptacopan (LNP023): Applied Workflows in Complement Research

  2026-07-10

  Iptacopan (LNP023) enables precise, reversible inhibition of the alternative complement pathway, offering robust experimental control in cellular and animal models of complement-mediated disease. Its oral bioavailability and high selectivity make it a differentiated tool for both translational research and advanced hemolysis assays.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Deep Mechanistic

  2026-07-09

  Explore how the One-step TUNEL Cy3 Apoptosis Detection Kit enables advanced, mechanistic interrogation of apoptotic DNA fragmentation in tissues and cultured cells. This article uniquely connects molecular detection principles to translational workflow choices, providing researchers with actionable guidance grounded in recent breakthroughs.

• PP 1: Precision Src Family Tyrosine Kinase Inhibitor for Fun

  2026-07-09

  Explore how PP 1, a leading Src family tyrosine kinase inhibitor, empowers researchers to dissect kinase signaling with unparalleled selectivity. This article uniquely examines PP 1's translational relevance and assay design considerations, including insights from recent cardiac safety research.

• Cholesterol Impedes Intracellular Trafficking of Lipid Nanop

  2026-07-08

  The referenced study demonstrates that increasing cholesterol content in lipid nanoparticles (LNPs) hinders their intracellular trafficking, leading to impaired nucleic acid cargo delivery. This work provides mechanistic insights into how LNP composition affects endosomal escape, with implications for optimizing nonviral nucleic acid delivery systems.

• Murine RNase Inhibitor: Advancing RNA Integrity in RT-PCR

  2026-07-08

  Murine RNase Inhibitor from APExBIO sets a new standard for RNA protection in high-sensitivity assays, outperforming traditional human-derived inhibitors. Its oxidation resistance and specificity make it indispensable for workflows such as cDNA synthesis, real-time RT-PCR, and in vitro transcription.

• TCF25 Regulates Lysosomal Acidification in Glucose Starvatio

  2026-07-07

  Ren et al. identify TCF25 as a pivotal nutrient sensor that enhances lysosomal acidification via V-ATPase, coordinating metabolic adaptation and lysosome-dependent cell death during glucose starvation. These findings clarify mechanisms underlying cellular energy stress responses and suggest new targets for metabolic and ischemic disease intervention.

• Disentangling Drug-Induced Proliferation Arrest and Cell Dea

  2026-07-07

  Schwartz's dissertation introduces a refined approach for evaluating anti-cancer drug responses, distinguishing proliferation arrest from cell death using nuanced in vitro methods. This innovation improves the interpretability and predictive value of preclinical screening, with practical relevance for agents like Salinomycin in hepatocellular carcinoma research.

• CD44-Mediated Metabolic Rewiring in IDH1-Mutant Leukemia

  2026-07-06

  This study uncovers a critical role for CD44 in sustaining the oncometabolite 2-hydroxyglutarate (2-HG) production in IDH-mutant acute myeloid leukemia (AML) by rewiring cellular metabolism to favor NADPH generation. Targeting the CD44-mediated pathway, in conjunction with mutant IDH1 inhibition, represents a promising therapeutic strategy to overcome resistance and restore differentiation in AML.

• Isorhamnetin: Mechanistic Insights for Oxidative Stress and

  2026-07-06

  Isorhamnetin, a flavonoid known as 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one, modulates PI3K/Akt and MAPK signaling to reduce oxidative stress and apoptosis in oocyte maturation models. APExBIO’s Isorhamnetin (N1358) provides a stable, research-grade reagent for cell signaling and stress biology. Recent studies validate its efficacy in enhancing oocyte survival and function.

15877 records 1/1059 page Next 12345 下5页 Last page